Corriente Advisors, LLC Lantern Pharma Inc. Transaction History

Corriente Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.11 - $11.04 $4.45 Million - $6.91 Million	-625,873 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.53 - $14.93 $321,070 - $455,230	-30,491 Reduced 4.65%	625,873 $7 Million
Q2 2021 Aug 16, 2021	SELL	$12.94 - $19.89 $743,299 - $1.14 Million	-57,442 Reduced 8.05%	656,364 $9.58 Million
Q1 2021 May 18, 2021	BUY	$14.34 - $21.92 $10.2 Million - $15.6 Million	713,806 New	713,806 $12.9 Million

1.26M

42.8K

5.6K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $40.9M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Corriente Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corriente Advisors, LLC with notifications on news.